Pathfinders in Biopharma

Pharma Understands Phase One Data – But Does the Market?


Listen Later

Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.

...more
View all episodesView all episodes
Download on the App Store

Pathfinders in BiopharmaBy RBC Capital Markets

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Pathfinders in Biopharma

View all
The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

117 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

Business Of Biotech by Matt Pillar

Business Of Biotech

84 Listeners

RBC's Markets in Motion by RBC Capital Markets

RBC's Markets in Motion

40 Listeners

Industries in Motion by RBC Capital Markets

Industries in Motion

10 Listeners

Powering Sustainable Ideas by RBC Capital Markets

Powering Sustainable Ideas

0 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,443 Listeners

Macro Minutes by RBC Capital Markets

Macro Minutes

1 Listeners

Strategic Alternatives by RBC Capital Markets

Strategic Alternatives

17 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,332 Listeners